Innate Pharma SA (NAS:IPHA)
$ 1.9 0.05 (2.7%) Market Cap: 153.81 Mil Enterprise Value: 93.89 Mil PE Ratio: 0 PB Ratio: 4.75 GF Score: 56/100

Innate Pharma SA KOL Event Transcript

Dec 12, 2023 / 03:00PM GMT
Release Date Price: $2.39 (-2.05%)
Operator

Lacutamab KOL event. (Operator Instructions) I'll now turn the conference over to Henry Wheeler, VP of Investor Relations and Communication. Please go ahead.

Henry Wheeler Innate Pharma SA;VP
IR & Communications

Thank you. Good morning, good afternoon, and welcome, everyone. Thank you for joining today's Innate KOL call on lacutamab where we look forward to sharing updates from data presented at ASH here in San Diego over the weekend. Today's presentation is available on the IR section of our website.

On slide 2, before we start, I would like to remind you that we will be making forward-looking statements regarding the financial outlook in addition to product developments. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted.

On slide 3, on today's call, we will be joined by Dr. Sonia Quaratino, our Chief Medical Officer. And we'd also like to thank Dr. Porcu, Director, Division of Hematological Malignancies and Hematopoietic Stem Cell Transplantation,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot